Commentary: Understanding sources of complexity in chronic diseases - The importance of integration of genetics and epidemiology

International Journal of Epidemiology

Volumn 35, Issue 3, 2006, Pages 590-592

  Merikangas, Kathleen Ries ^a   Low, Nancy C P ^a   Hardy, John ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAUSAL ATTRIBUTION; CHRONIC DISEASE; ENVIRONMENTAL FACTOR; EPISTASIS; GENE IDENTIFICATION; GENETIC EPIDEMIOLOGY; GENETIC HETEROGENEITY; GENETIC RISK; GENOMICS; GENOTYPE; HUMAN; HUMAN GENETICS; NOTE; PHENOTYPE; PHENOTYPIC VARIATION; PLEIOTROPY; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

CHRONIC DISEASE; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGIC METHODS; GENETIC DISEASES, INBORN; HUMANS;

EID: 33745619786     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyl007     Document Type: Note

References (45)

1. Buchanan AV, Weiss KM, Fullerton SM. Dissecting complex disease: The quest for the philosopher's stone? Int J Epidemiol 2006;35: 562-71.
2. Terwilliger JD, Weiss KM. Confounding, ascertainment bias, and the blind quest for a genetic 'fountain of youth'. Ann Med 2003;35:532-44.
3. Altmuller J, Palmer LJ, Fischer G, Scherb H, Wjst M. Genomewide scans of complex human diseases: True linkage is hard to find. Am J Hum Genet 2001;69:936-50.
4. Botstein D, Risch N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet 2003;33(Suppl.):228-37.
5. Glazier AM, Nadeau JH, Aitman TJ. Finding genes that underlie complex traits. Science 2002;298:2345-49.
6. Merikangas K, Risch N. Genomic priorities and public health. Science 2003;304:1445-47.
7. Palmer LJ. The New Epidemiology: Putting the pieces together in complex disease aetiology. Int J Epidemiol 2004;33:925-28.
8. Terwilliger JD, Goring HH. Gene mapping in the 20th and 21st centuries: statistical methods, data analysis, and experimental design. Hum Biol 2000;72:63-132.
9. Cavalli-Sforza L, Bodner W. The Genetics of Human Populations. San Francisco, CA: WH Freeman and Co., 1971.
10. Vogel F, Motulsky A. Human Genetics. 2nd edn. New York: Springer Verlag, 1998.
11. Langbehn DR, Brinkman RR, Falush D, Paulsen JS, Hayden MR. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clin Genet 2004;65:267-77.
12. Joutel A, Bousser MG, Biousse V et al. A gene for familial hemiplegic migraine maps to chromosome 19. Nat Genet 1993;5:40-45.
13. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer,s disease: progress and problems on the road to therapeutics. Science 2002;297:353-56.
14. Hardelid P, Dezateux C. Neonatal screening for inborn errors of metabolism. Lancet 2005;365:2176.
15. Pollitt RJ, Green A, McCabe CJ et al. Neonatal screening for inborn errors of metabolism: Cost, yield and outcome. Health Technol Assess 1997;1:i-iv, 1-202.
16. Klein RJ, Zeiss C, Chew EY et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005;308:385-89.
17. Edwards AO, Ritter R 3rd, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science 2005;308:421-24.
18. Haines JL, Hauser MA, Schmidt S et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005;308:419-21.
19. Burkhardt H, Huffmeier U, Spriewald B et al. Association between protein tyrosine phosphatase 22 variant R620W in conjunction with the HLA-DRB1 shared epitope and humoral autoimmunity to an immunodominant epitope of cartilage-specific type II collagen in early rheumatoid arthritis. Arthritis Rheum 2005;54:82-89.
20. Carlton VE, Hu X, Chokkalingam AP et al. PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis. Am J Hum Genet 2005;77:567-81.
21. van Oene M, Wintle RF, Liu X et al. Association of the lymphoid tyrosine phosphatase R620W variant with rheumatoid arthritis, but not Crohn's disease, in Canadian populations. Arthritis Rheum 2005;52:1993-98.
22. Seldin MF, Shigeta R, Laiho K et al. Finnish case-control and family studies support PTPN22 R620W polymorphism as a risk factor in rheumatoid arthritis, but suggest only minimal or no effect in juvenile idiopathic arthritis. Genes Immun 2005;6:720-22.
23. Davies P, Arbyn M, Dillner J et al. A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening. Int J Cancer 2005.
24. Knudson AG Jr. Mutation and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci USA 1971;68:820-23.
25. Risch N. Linkage strategies for genetically complex traits. I. Multilocus models. Am J Hum Genet 1990;46:222-28.
26. Clayton D, McKeigue PM. Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet 2001; 358:1356-60.
27. Hemminki K, Li X. Familial risks of cancer as a guide to gene identification and mode of inheritance. Int J Cancer 2004;110:291-94.
28. Hemminki K, Rawal R, Chen B, Bermejo JL. Genetic epidemiology of cancer: from families to heritable genes. Int J Cancer 2004;111:944-50.
29. Risch N. Linkage strategies for genetically complex traits. II. The power of affected relative pairs. Am J Hum Genet 1990;46:229-41.
30. US Department of Health and Human Services Web Site. U.S. Surgeon General's Family History Initiative. Available at: Http://www.his.gov/ familyhistory (Accessed).
31. Yoon PW, Scheuner MT, Khoury MJ. Research priorities for evaluating family history in the prevention of common chronic diseases. Am J Prev Med 2003;24:128-35.
32. Morton N. Outline of Genetic Epidemiology. New York: Karger, 1982.
33. Khoury M, Beaty T, Cohen B. Fundamentals of Genetic Epidemiology. New York: Oxford University Press; 1993.
34. Beaty TH. Evolving methods in genetic epidemiology. I. Analysis of genetic and environmental factors in family studies. Epidemiol Rev 1997;19:14-23.
35. Beaty TH, Khoury MJ. Interface of genetics and epidemiology. Epidemiol Rev 2000;22:120-25.
36. Merikangas K. Genetic epidemiology: Bringing genetics to the population - the NAPE Lecture 2001. Acta Psychiatr Scand 2002;105:3-13.
37. Dekker MC, van Duijn CM. Prospects of genetic epidemiology in the 21st century. Eur J Epidemiol 2003;18:607-16.
38. Ioannidis JP, Bernstein J, Boffetta P et al. A network of investigator networks in human genome epidemiology. Am J Epidemiol 2005; 162:302-04.
39. Khoury MJ, Millikan R, Little J, Gwinn M. The emergence of epidemiology in the genomics age. Int J Epidemiol 2004;33:936-44.
40. Risch NJ. Searching for genetic determinants in the new millennium. Nature 2000;405:847-56.
41. Khoury MJ, Yang Q. The future of genetic studies of complex human diseases: An epidemiologic perspective. Epidemiology 1998; 9:350-54.
42. Thomas DC. Genetic epidemiology with a capital 'E'. Genet Epidemiol 2000;19:289-300.
43. Morton NE. Unsolved problems in genetic epidemiology. Hum Hered 2000;50:5-13.
44. Schork NJ, Cardon LR, Xu X. The future of genetic epidemiology. Trends Genet 1998;14:266-72.
45. Peltonen L, McKusick VA. Genomics and medicine. Dissecting human disease in the postgenomic era. Science 2001;291:1224-29.